Form 4: Lyell Immunopharma Executive Sells Shares
Insider Transaction (Form 4)
David Shook, Chief Medical Officer of Lyell Immunopharma, Inc., sold 500 shares of common stock on September 10, 2026 for $12.70 per share.
Summary
- Open-market sale: disposed of 500 Common Stock at $12.70 ($6,350) on September 10, 2026; holds 20,423 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $6,350 of stock on the open market.
Insider Transactions
David Shook — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-10 | Open-market sale | Common Stock | 500 | $13 | $6.3K | 20,423 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-10 | Open-market sale (500 shares) |
Keywords
insider transaction, Form 4, LYEL, Lyell Immunopharma, Inc., bearish, David Shook
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.